Clinical Trial Update: Microbiotherapy in Characterized Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for microbiotherapy in characterized depressive disorder is in early status with unspecified results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Depression, Depressive Disorder | Phase 2 | Status: UNKNOWN